Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jamal G. Misleh"'
Autor:
Nicole F. Laslett, SuJung Park, Gregory A. Masters, David D. Biggs, Charles J. Schneider, Jamal G. Misleh, Kathir Suppiah, Pamela S. Simpson, Stephen Grubbs, Timothy F. Wozniak, Michael Guarino
Publikováno v:
Cancer Medicine, Vol 7, Iss 7, Pp 2969-2973 (2018)
Abstract Lung cancer remains the leading cause of cancer death throughout the world. Despite new chemotherapeutic, immunomodulating and molecularly targeted agents, patients with locally advanced or metastatic disease still have a poor prognosis. Thi
Externí odkaz:
https://doaj.org/article/2297a7a08b024d68b2d231ee20dac90e
Autor:
Thomas E. Witzig, Michael B. Tomblyn, Jamal G. Misleh, Ebenezer A. Kio, Robert M. Sharkey, William A. Wegener, David M. Goldenberg
Publikováno v:
Haematologica, Vol 99, Iss 11 (2014)
A lingering criticism of radioimmunotherapy in non-Hodgkin lymphoma is the use of cold anti-CD20 antibody along with the radiolabeled anti-CD20 antibody. We instead combined radioimmunotherapy with immunotherapy targeting different B-cell antigens. W
Externí odkaz:
https://doaj.org/article/78dc7ab480264fe09565bfce3e4eef85
Autor:
Brandon E. Kremer, Jason D. Christie, Jamal G. Misleh, Ran Reshef, Vivek N. Ahya, Stephen J. Schuster, Donald E. Tsai, Nancy P. Blumenthal, Denis Hadjiliadis, Robert M. Kotloff, Edward A. Stadtmauer
Publikováno v:
The Journal of Heart and Lung Transplantation. 31:296-304
Background Post-transplant lymphoproliferative disorder (PTLD) is a complication of organ transplantation. The risk of developing PTLD varies depending on a number of factors, including the organ transplanted and the degree of immunosuppression used.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68f9a04c86f8a4a0dae714b192eb5c4b
https://doi.org/10.1016/j.healun.2011.10.013
https://doi.org/10.1016/j.healun.2011.10.013